A specific effect of intravenous immune globulin (IVIG) on the outcome
of pregnancy in patients with a history of habitual abortion has been
postulated as an alternative to immunotherapy with allogeneic leucocy
tes. The results of different pilot studies have been promising, demon
strating a successful outcome of pregnancy in approximately 80% of tre
ated patients. However, the evaluation and interpretation of the study
results has to take into account that the probability of a successful
pregnancy in women with a history of three spontaneous abortions is a
bout 60% without treatment. Specific pharmacological effects therefore
have to be verified in controlled studies in order to rule out psycho
logical (placebo) effects. A specific therapeutic effect could not be
verified in a German randomized, double-blind, multicentre trial in co
mparison to human albumin 5% which was used as a placebo. The result o
f another controlled study currently underway in the USA is expected.